Cellcept and Amitiza drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cellcept (mycophenolate mofetil) and Amitiza (lubiprostone). Common drug interactions include chest pain among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Cellcept and Amitiza. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

What is Amitiza?

Amitiza has active ingredients of lubiprostone. It is often used in constipation. eHealthMe is studying from 10,567 Amitiza users. Check the latest studies of Amitiza.

On Jul, 15, 2026

25 people who take Cellcept and Amitiza together, and have interactions are studied.

What are the common drug interactions of Cellcept and Amitiza, by gender? *:

female:

Chest pain
Dyspnoea exertional (breathlessness or shortness of breath)
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Cytomegalovirus test positive
Cough
Diplegia (paralysis of corresponding parts on both sides of the body)
Thrombosis (formation of a blood clot inside a blood vessel)
Acute respiratory failure
Breast cancer female
Cardiac failure congestive

male:

Abdominal pain
Angioedema (rapid swelling of the dermis)
Flushing (the warm, red condition of human skin)
Hyperhidrosis (abnormally increased sweating)
Hypoaesthesia (reduced sense of touch or sensation)
Oedema (fluid collection in tissue)
Pain in extremity
Retinal haemorrhage (bleeding from retina)
Thrombocytopenia (decrease of platelets in blood)
Visual impairment

What are the common drug interactions of Cellcept and Amitiza, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Cytomegalovirus test positive

30-39:

n/a

40-49:

Abdominal pain
Angioedema (rapid swelling of the dermis)
Arthralgia (joint pain)
Blood pressure fluctuation
Burning sensation
Chest pain
Dizziness
Drug hypersensitivity
Dysphagia (a condition in which swallowing is difficult or painful)
Dyspnoea (difficult or laboured respiration)

50-59:

Diplegia (paralysis of corresponding parts on both sides of the body)
Thrombosis (formation of a blood clot inside a blood vessel)
Alopecia (absence of hair from areas of the body)
Balance disorder
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Dysuria (painful or difficult urination)
Fall
Peripheral swelling
Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
Wrist fracture

60+:

Chest pain
Dyspnoea exertional (breathlessness or shortness of breath)
Eructation (release of gas from the digestive tract)
Erythema (redness of the skin)
Fall
Headache (pain in head)
Ingrowing nail
Knee arthroplasty
Localised infection (infection at the single location)
Lung neoplasm malignant (cancer tumour of lung)

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 24.00%
Sinusitis (inflammation of sinus): 5 people, 20.00%
Sinus Congestion (blockage of sinus): 5 people, 20.00%
Cough: 5 people, 20.00%
Dermatitis Allergic (inflammation of the skin due allergic reaction): 5 people, 20.00%
Diabetes: 5 people, 20.00%
Dry Mouth: 5 people, 20.00%
Furuncle (infection of the hair follicle): 5 people, 20.00%
High Blood Pressure: 5 people, 20.00%
Hypersensitivity: 5 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and Amitiza?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously